Akanda (AKAN) Assets Average (2021 - 2025)
Akanda's (AKAN) quarterly Assets Average came in at $6.2 million in Q4 2025, down 30.59% year-on-year from $8.9 million in Q4 2024, and down 12.16% quarter-over-quarter from $7.1 million in Q2 2025.
Akanda (AKAN) Assets Average (2021 - 2025) Analysis & Trends
Akanda's Assets Average history runs 5 years deep, the most recent figure standing at $6.2 million for Q4 2025.
- On a quarterly basis, Assets Average fell 30.59% year-over-year to $6.2 million in Q4 2025; TTM through Dec 2025 was $6.2 million, a 30.59% decrease from a year earlier, with the FY2025 full-year figure at $7.1 million, down 15.78% from the prior year.
- Assets Average declined to $6.2 million in Q4 2025 per AKAN's latest filing, from $7.1 million in the prior quarter.
- Across five years, Assets Average topped out at $41.2 million in Q4 2022 and bottomed at $6.2 million in Q4 2021.
- The 5-year median for Assets Average is $9.4 million (2024), against an average of $18.4 million.
- Across the five-year window, Assets Average surged 569.43% in 2022 and plunged 75.09% in 2024, its largest moves.
- Year by year, Assets Average stood at $6.2 million in 2021, then jumped by 569.43% to $41.2 million in 2022, then plunged by 45.02% to $22.7 million in 2023, then tumbled by 60.57% to $8.9 million in 2024, then sank by 30.59% to $6.2 million in 2025.
- Per Business Quant, the three latest AKAN Assets Average figures stand at $6.2 million (Q4 2025), $7.1 million (Q2 2025), and $8.9 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.32 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 99.52 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 7.30 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 68.63 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 37.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.77 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.29 Bn |
| 10 | Akanda | 556,353.85 | 556,353.85 | - | 6.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.21 Mn |
| Jun 30, 2025 | 7.06 Mn |
| Dec 31, 2024 | 8.94 Mn |
| Jun 30, 2024 | 9.40 Mn |
| Dec 31, 2023 | 22.67 Mn |
| Jun 30, 2023 | 37.75 Mn |
| Dec 31, 2022 | 41.24 Mn |
| Jun 30, 2022 | 25.76 Mn |
| Dec 31, 2021 | 6.16 Mn |